Heme oxygenase in experimental intracerebral hemorrhage: The benefit of tin-mesoporphyrin

被引:88
|
作者
Koeppen, AH
Dickson, AC
Smith, J
机构
[1] VA Med Ctr, Serv Neurol, Albany, NY 12208 USA
[2] VA Med Ctr, Res Serv, Albany, NY 12208 USA
[3] Albany Med Coll, Dept Neurol, Albany, NY 12208 USA
[4] Albany Med Coll, Dept Pathol, Albany, NY 12208 USA
[5] GE Co, Global Res Ctr, Niskayuna, NY USA
关键词
cerebral hemorrhage; heme oxygenase (decyclizing); iron; macrophages; metalloporphyrins; microglia; neuropil;
D O I
10.1093/jnen/63.6.587
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The prognosis of intracerebral hemorrhage (ICH) is unfavorable. Beyond immediate mass effect and tissue destruction. ICHs cause additional neuronal loss in a "perifocal reactive zone." Heme in ICH induces heme oxygenase-1 (HO-1), and the action of this enzyme on heme yields ferrous iron, biliverdin, and carbon monoxide. Iron is ultimately converted to ferritin and hemosiderin. Free iron is tissue-toxic, and inhibition of HO-1 should provide protection against additional damage. Experimental ICHs were made in adult rabbits by the stereotaxic injection of autologous blood, and the induction of HO-1 and increase in ferritin were followed by confocal immunofluorescence microscopy. Heme diffused rapidly through perivascular spaces, and HO-1 reaction product first Occurred in perivascular cells and microglia. At this stage, HO-1 and ferritin showed extensive colocalization. As ICH resolution progressed, HO-1 immunoreactivity faded while ferritin and hemosiderin continued to accumulate. This process was accompanied by a gradient of destruction of neuronal cell bodies and dendrites in the perifocal reactive zone. In an effort to inhibit HO-1, repeated intravenous injections of tin-mesoporphyrin IX (SnMP) were given to ICH-bearing rabbits. The ICH disrupted the blood-brain barrier sufficiently to allow SnMP to enter the brain in pharmacological amounts, and the metalloporphyrin provided significant protection against neuronal loss.
引用
收藏
页码:587 / 597
页数:11
相关论文
共 50 条
  • [31] Naive Human T Cells Are Activated and Proliferate in Response to the Heme Oxygenase-1 Inhibitor Tin Mesoporphyrin
    Burt, Trevor D.
    Seu, Lillian
    Mold, Jeffrey E.
    Kappas, Attallah
    McCune, Joseph M.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (09): : 5279 - 5288
  • [32] Tin-mesoporphyrin in the Treatment of Severe Hyperbilirubinemia in a Very-low-birth-weight Infant
    Pradeep Reddy
    Shakuntala Najundaswamy
    Rajeev Mehta
    Anna Petrova
    Thomas Hegyi
    Journal of Perinatology, 2003, 23 (6) : 507 - 508
  • [33] Astrocyte Overexpression of Heme Oxygenase-1 Improves Outcome After Intracerebral Hemorrhage
    Chen-Roetling, Jing
    Song, Wei
    Schipper, Hyman M.
    Regan, Christopher S.
    Regan, Raymond F.
    STROKE, 2015, 46 (04) : 1093 - 1098
  • [34] SELECTIVE ASTROCYTE OVEREXPRESSION OF HEME OXYGENASE-1 IS PROTECTIVE AFTER INTRACEREBRAL HEMORRHAGE
    Chen-Roetling, J.
    Song, W.
    Schipper, H. M.
    Regan, R. F.
    JOURNAL OF NEUROTRAUMA, 2014, 31 (12) : A78 - A78
  • [35] Research Progress in Understanding the Relationship Between Heme Oxygenase-1 and Intracerebral Hemorrhage
    Li, Qian-Qian
    Li, Lan-Jun
    Wang, Xin-Yu
    Sun, Yu-Ying
    Wu, Jun
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [36] Heme oxygenase 2 deficiency increases brain swelling and inflammation after intracerebral hemorrhage
    Wang, J.
    Dore, S.
    NEUROSCIENCE, 2008, 155 (04) : 1133 - 1141
  • [37] Efficacy of chromium mesoporphyrin in inhibiting heme oxygenase activity in heme-loaded newborn mice
    Morisawa, T.
    Xiao, H. H.
    Wong, R. J.
    Bhutani, V. K.
    Vreman, H. J.
    Stevenson, D. K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 198 - 198
  • [38] Tin mesoporphyrin combined with heme for treatment of acute porphyria.
    Anderson, KE
    Lee, C
    Egger, NG
    Kormos-Hallberg, C
    Goeger, DE
    Drummond, GS
    Kappas, A
    HEPATOLOGY, 2002, 36 (04) : 337A - 337A
  • [39] Targeting the Nrf2-Heme Oxygenase-1 Axis after Intracerebral Hemorrhage
    Chen-Roetling, Jing
    Regan, Raymond F.
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (15) : 2226 - 2237
  • [40] No Benefit of 3% Hypertonic Saline Following Experimental Intracerebral Hemorrhage
    Kung, Tiffany F. C.
    Kalisvaart, Anna C. J.
    Suerte, Angely Claire C.
    Jickling, Glen C.
    van Landeghem, Frank K. H.
    Colbourne, Frederick
    NEUROTOXICITY RESEARCH, 2024, 42 (06)